title: Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH.
authors.affiliation: Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
authors.forename: P
authors.initials: P
authors.lastname: Collins
authors.affiliation: The Royal Free Foundation Hospital, University College London, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Abdul-Kadir
authors.affiliation: Haemostasis and Thrombosis Unit, Manchester Royal Infirmary, Manchester, UK.
authors.forename: J
authors.initials: J
authors.lastname: Thachil
mesh_terms: D000925:Anticoagulants / Q000737:chemistry / Q000627:therapeutic use*; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000188:drug therapy*; D001803:Blood Transfusion; D002309:Cardiology / Q000592:standards; D015942:Factor VIIa / Q000737:chemistry; D005260:Female; D005340:Fibrinogen / Q000737:chemistry; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007391:International Cooperation; D009774:Obstetrics / Q000592:standards; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D049590:Postpartum Period; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011516:Prothrombin / Q000737:chemistry; D011994:Recombinant Proteins / Q000737:chemistry; D012955:Societies, Medical; D014148:Tranexamic Acid / Q000737:chemistry
chemical_list: D000925:Anticoagulants; D011994:Recombinant Proteins; D014148:Tranexamic Acid; D011516:Prothrombin; D005340:Fibrinogen; C103587:recombinant FVIIa; D015942:Factor VIIa